Bicycle Therapeutics PLC (BCYC) income statement
BCYCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 11/3080% below fair value
$3.11−0.09 (-2.81%)
Close on Nov 18, 2026Market cap $217.99MP/E –Yield 0.00%
Bicycle Therapeutics PLC income statement
Ratios
Latest available, balances at Sep 30, 2026
Profitability, TTM
- Gross margin
- –
- Operating margin
- -189.4%
- Net margin
- -169.8%
- Return on equity, FY2025
- -31.2%
Financial strength
- Current ratio
- 12.09
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 1057.0%
Valuation
- P/E ratio
- –
- Price to sales
- 2.61
- Price to book
- 0.43
- Dividend yield
- 0.00%
See a number that looks wrong?